Summary. The outputs of prostaglandin (PG) E-2 and 6-oxo-PGF-1\g=a\ from the early pregnant rat uterus superfused in vitro were significantly higher (P < 0\m=.\05) on Day 4 (09:00\p=n-\10:00h) and Day 5 (14:00\p=n-\15:00h) than on Day 2 (09:00\p=n-\10:00h) and Day 5 (14:00\p=n-\15:00h). PGF-2\g=a\ output was significantly higher (P < 0\m=.\05)only on Day 5 (09:00\p=n-\10:00h). PGE-2 was the major PG released at all times, although the amounts of PGF-2\g=a\and/or 6-oxo-PGF-1\g=a\released were often only slightly less. These findings are consistent with uterine PGs having a role in implantation in the rat.
Introduction
There is much evidence that increased prostaglandin (PG) production by the uterus is necessary for implantation (on Day 5) in the rat (see Kennedy & Armstrong, 1981) . The concentrations of PGE-2, PGF-2a and 6-oxo-PGF-la (which reflects PGI-2 production) are higher at the implan¬ tation sites than in the surrounding areas (Kennedy, 1977; Kennedy & Zamecnik, 1978) , and indomethacin treatment delays or prevents implantation in the rat (Kennedy, 1977; Phillips & Poyser, 1981) . There is little information on the output of PGs from the early pregnant rat uterus, except for one study which reported that the PGF-2a concentration, but not the PGE-2 concentration, in the uterine venous plasma was increased on Day 5 (Shaikh, Naqvi & Saksena, 1977) . The PGI-2 concentration was not measured. Consequently, the outputs of PGs from the early pregnant rat uterus superfused in vitro have been measured. Such an in-vitro technique avoids contamination by 'blood products' and has previously been shown to monitor accurately PG release in vivo from the guinea-pig uterus (Poyser & Brydon, 1983 
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before being assayed for progesterone as described previously (Poyser & Horton, 1975; Fenwick, Jones, Naylor, Poyser & Wilson, 1977; Poyser, 1984a) . All the samples were measured in 2 assays.
The uterus from each rat was removed, and the two uterine horns were separated, blotted dry and weighed. Each uterine horn was 'opened' by cutting longitudinally and was suspended in an organ bath attached to an isotonic lever under a load of 1 g. The uterine horns were superfused (5 ml/min) with Krebs' solution (for composition see Mitchell, Poyser & Wilson, 1977) at 37°C and pre-gassed with 5% C02 and 95% 02. After an initial settling period of 60 min for all uterine horns, samples of superfusate were collected for 10-min periods consecutively over the next 90 min (i.e. 9 samples) from the uterine horns of rats killed between 09:00 and 10:00 h on Days 2 and 4, and between 14:00 and 15:00honDay 5. A23187(l pg/ml; Sigma Chemical Co. Ltd, Poole, U.K.)was added to the Krebs' solution during the collection of Samples 4, 5 and 6 from one uterine horn of each of these rats. Samples of superfusate were collected for 10-min periods consecutively for 100 min (i.e. 10 samples) from the uterine horns of rats killed between 09:00 and 10:00 h on Day 5. Trifluoperazine (100 µ ; Smith, Kline and French Labs. Ltd, Welwyn Garden City, U.K.) was added to the Krebs' solution during the collection of Samples 4-7 from one uterine horn of each rat, and A23187 (1 pg/ml) was added to the Krebs' solution during the collection of Samples 6 and 7 from both uterine horns.
After collection, PGs were extracted and stored and the amounts of PGF-2a, PGE-2 and 6-oxo-PGF-la present in the samples were measured by radioimmunoassay as described previously (Poyser, 1984a) . The intra-assay coefficients of variation, calculated from the variation between the duplicate results obtained, were 9-8% (PGF-2oc), 10-4% (PGE-2) and 10-7% (6-oxo-PGF-la). The inter-assay coefficients of variation, calculated from the results obtained by incorporating a known amount of the appropriate PG into each assay, were 9-5% (PGF-2a), 10-3% (PGE-2) and 11-5% (6-oxo-PGF-la). 
Results
The mean average outputs of PGF-2a, PGE-2 and 6-oxo-PGF-la during the first 50 min of sample collection from one uterine horn of the rats studied are shown in Table 1 . PGE-2 was released in the greatest amounts on each day, although the outputs of PGF-2a and/or 6-oxo-PGF-la were often only slightly lower. The outputs of PGE-2 and 6-oxo-PGF-la were significantly higher (P < Trifluoperazine (100 µ ) caused a small increase in uterine PG output which was significant (P< 0-05) for 6-oxo-PGF-la. However, trifluoperazine (100 µ ) prevented the increase in outputs of PGF-2a and 6-oxo-PGF-la induced by A23187 on Day 5 (a.m.) (Text-fig. 2b ).
Discussion
Uterine PG output in the pregnant rat was increased for 24 h immediately before the presumed time of implantation. PGE-2 was the major PG produced, which is consistent with PGE-2 being the only PG capable of causing the increase in uterine capillary permeability associated with implantation (Kennedy, 1979a, b (Kennedy, Martel & Psychoyos, 1983) , suggesting that the uterus is more responsive to the increased PGE-2 production on Day 5 than on Day 4. PGE-2, PGF-2a and PGI-2 will all induce decidualization of the rat uterus (Sananes, Baulieu & Le Goascogne, 1981; Miller & Morchoe, 1982a; Kennedy & Lukash, 1982) . The increased production of these PGs by the rat uterus on Days 4 and 5 is consistent with PGs having a role in the decidualization process, especially as decidualization of the rat uterus in response to an appropriate stimulus is prevented by indomethacin (Tobert, 1976; Sananes et ai, 1981 ; Miller & Morchoe, 1982b) .
The increased output of PGF-2a from the rat uterus on Day 5 (a.m.) in vitro is consistent with the in vivo findings of Shaikh et ai (1977) . However, these authors failed to find an increase in uterine PGE-2 output on Days 4 and 5, and PGF-2a output always greatly exceeded PGE-2 output. Differences in experimental design may be the reason for the inconsistencies between the two studies. Oestradiol acting on a progesterone-primed uterus is the optimal steroidal stimulus for increased PGF-2a and PGE-2 secretion from the ovariectomized rat uterus in vivo, with maximum PG output occurring 12 h after the oestradiol injection (Castracane & Jordan, 1976 (Brown, Gosden & Poyser, 1984 ). It appears that other factors, as well as or other than the ovarian steroid hormones, form the stimulus for increased uterine PG production on Days 4 and 5.
The activities of phospholipase A-2 (PLA-2 ; the enzyme that releases arachidonic acid from phospholipids) and PGH-2 synthetase (the enzyme which converts arachidonic acid into PGH-2) are greatest on Day 4 (a.m.) and Day 5 (a.m.), respectively (Cox, Cheng & Dey, 1982; Phillips & Poyser, 1981) . These findings are consistent with the increased outputs of PGs on Days 4 (a.m.) and 5 (a.m.), although it would appear that the absolute activity of neither enzyme is solely responsible for controlling the amounts of PGs synthesized by the uterus since total PG production is increased to a similar extent on both days.
The calcium ionophore, A23187, stimulated PGF-2a output, except on Day 4 (a.m.), and 6-oxo-PGF-la output, but had little effect on PGE-2 output from the early pregnant rat uterus. Similar actions of A23187 have been reported for the non-pregnant and early pregnant guinea-pig uterus (Poyser & Brydon, 1983; Poyser, 1984a) , an effect which is dependent upon extracellular Ca2+ (Poyser, 1984b) . A23187 has been reported to stimulate 6-oxo-PGF-la output from the myometrium, but not from the endometrium, of rat uteri superfused in vitro (Campos, Liggins & Seamark, 1980) . In the present study, it is not clear why A23187 failed to increase PGF-2a output from the rat uterus on Day 4 (a.m.). In the study of Campos et ai (1980) , A23187 had no effect on PGF-2a release from the endometrium, the major site of PGF-2a synthesis in the rat uterus (Williams, Sneddon & Harney, 1974; Brown & Poyser, 1985) , and only had a small stimulatory effect on PGF-2a release from the myometrium. These rats were ovariectomized and treated with oestradiol, so perhaps oestradiol had prevented the stimulatory action of A23187 on uterine PGF2a output in some way. Consequently, the peak of oestradiol between Days 3 and 4 (Watson et ai, 1975) may be responsible for the lack of effect of A23187 on PGF-2a release on Day 4 (a.m.). The greatest output of PGF-2a and 6-oxo-PGF-la from the uterus in response to A23187 occurred on Day 5 (a.m.). This suggests that PGH-2 synthetase activity (which is maximal on Day 5) and not PLA-2 activity (which is maximal on Day 4) determines the maximum amounts of PGs which can be synthesized by the uterus.
Trifluoperazine, a calmodulin antagonist, had no inhibitory effect on the high basal outputs of PGs from the uterus on Day 5 (a.m.) and, in fact, it had a small stimulatory action. Nevertheless, trifluoperazine prevented the increase in PG output normally induced by A23187. Similar actions of trifluoperazine (100 µ ) have been reported for the guinea-pig uterus (Poyser, 1985) 
